Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran
Yıl: 2016 Cilt: 22 Sayı: 3 Sayfa Aralığı: 121 - 126 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran
Öz: Amaç: Parkinson hastalığı (PH) olan hastalarda, bilişsel durum ve uyku kalitesi ve bunların birlikteliğini değerlendirmektir.Gereç ve Yöntem: Bu analitik kesitsel çalışmada, PH olan 120 hasta, 22-Bahman ve 17-Shahrivar hastanelerinden seçildi. Demografik bilgi formu dolduruldu ve Parkinson şiddeti Hoehn ve Yahr (HY) ölçeği kullanılarak belirlendi. Pittsburgh Uyku Kalitesi İndeksi (PUKİ) ve Epworth uykululuk skalası (ESS), sırasıyla uyku kalitesini ve gündüz aşırı uykululuğun değerlendirilmesi için kullanılmıştır. Bilişsel durum Montreal Bilişsel Değerlendirme anket formu kullanılarak değerlendirildi.Bulgular: PH hastalarının yaş ortalaması 65,9±11,7 yıl idi ve bunların %67,5'i erkekti. Hastaların 27'sinde (%22,5) kognitif bozukluk, 87'sinde (%72,5) gündüz aşırı uykululuk ve 113'ünde (%94,2) kötü uyku kalitesi bulundu. PUKİ ortalama ve ESS skorları sırasıyla 9,03±4,70 ve 3,73±7,38 idi. Kognitif durum ve uyku kalitesi yanı sıra gündüz uykululuk arasında bir anlamlı ilişki saptandı (p<0,0001).Sonuç: Kognitif bozukluk ve kötü uyku kalitesi yanı sıra gündüz aşırı uykululuk arasında anlamlı bir ilişki vardır.
Anahtar Kelime: Konular:
İran'da Parkinson Hastalarında Uyku Kalitesi ve Kognitif Bozukluk
Öz: Objective: To evaluate the cognitive status and sleep quality and their association in patients with Parkinson's disease (PD).Materials and Methods: In this analytical cross-sectional study, 120 patients with PD were selected from 22-Bahman and 17-Shahrivar hospitals. Demographic information was recorded on a form and Parkinson's severity was determined using the Hoehn and Yahr scale (HY). Pittsburgh Sleep Quality Index (PSQI) and Epworth sleepiness scale (ESS) were used for the assessment of sleep quality and excessive daytime sleepiness, respectively. Cognitive status was assessed using the Montreal Cognitive Assessment questionnaire. Results: The mean age of patients with PD was 65.9±11.7 years, and 67.5% were men. Cognitive impairment was found in 113 (94.2%) patients, poor sleep quality in 87 (72.5%), and excessive daytime sleepiness in 27 (22.5%) patients. The mean PSQI and ESS scores were 9.03±4.70 and 7.38±3.73, respectively. There was a significant association between cognitive status and sleep quality, as well as daytime sleepiness (independent sample t-test, p<0.0001 for both). Conclusion: There is a significant association between cognitive impairment and poor sleep quality as well as excessive daytime sleepiness.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-22301.
- Qin Z, Zhang L, Sun F, Fang X, Meng C, Tanner C, Chan P; Chinese Parkinson Study Group. Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 2009;15:767-771.
- Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 2008;23:1428- 1434.
- Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD; PRIAMO study group. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009;24:1641-1649.
- Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990;5:280-285.
- Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13:895-899.
- Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU. Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol 2010;257:1073-1082.
- Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Högl B, Trenkwalder C. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-635.
- Zoccolella S, Savarese M, Lamberti P, Manni R, Pacchetti C, Logroscino G. Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies. Sleep Med Rev 2011;15:41-50.
- Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-199.
- Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2012;83:601-606.
- Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-560.
- Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ; ICICLE-PD Study Group. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 2014;82:308-316.
- Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options. CNS Drugs 2006;20:477-505.
- Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
- Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
- Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
- Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
- Farrahi Moghaddam J, Nakhaee N, Sheibani V, Garrusi B, Amirkafi A. Reliability and validity of the Persian version of the Pittsburgh Sleep Quality Index (PSQI-P). Sleep Breath 2012;16:79-82.
- Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545.
- Sadeghniiat Haghighi K, Montazeri A, Khajeh Mehrizi A, Aminian O, Rahimi Golkhandan A, Saraei M, Sedaghat M. The Epworth Sleepiness Scale: translation and validation study of the Iranian version. Sleep Breath 2013;17:419-426.
- Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695- 699.
- Emsaki G, Molavi H, Chitsaz A, Abtahi MM, Asgari K. Psychometric Properties of the Montreal Cognitive Assessment (MoCA) in Parkinson's Disease Patients in Isfahan. Journal of Isfahan Medical School 2011;29:1391- 1400.
- Yu SY, Sun L, Liu Z, Huang XY, Zuo LJ, Cao CJ, Zhang W, Wang XM. Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism. PLoS One 2013;8:e82924.
- Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ; ICICLE-PD Study Group. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 2014;82:308-316.
- Broeders M, de Bie RM, Velseboer DC, Speelman JD, Muslimovic D, Schmand B. Evolution of mild cognitive impairment in Parkinson disease. Neurology 2013;81:346-352.
- Najafi MR, Chitsaz A, Askarian Z, Najafi MA. Quality of sleep in patients with Parkinson's disease. Int J Prev Med 2013;4(Suppl 2):S229-233.
- Ashrafi F, Zali A, Pakdaman H, Johari K. Cognitive impairments in Parkinson's disease: Evidence from an Iranian population. Iran J Neurol 2012;11:151-154.
- Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson's disease. JAMA Neurol 2014;71:463-469.
- Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease. Parkinsonism Relat Disord 2013;19:806-811.
- Diederich NJ, Rufra O, Pieri V, Hipp G, Vaillant M. Lack of polysomnographic Non-REM sleep changes in early Parkinson's disease. Mov Disord 2013;28:1443-1446.
- Kim EJ, Baek JH, Shin DJ, Park HM, Lee YB, Park KH, Shin DH, Noh Y, Sung YH. Correlation of sleep disturbance and cognitive impairment in patients with Parkinson's disease. J Mov Disord 2014;7:13-18.
| APA | SAHEBZADEH N, BAF M, HOMAM S (2016). Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. , 121 - 126. |
| Chicago | SAHEBZADEH Narges,BAF Morteza Mazloum Farsi,HOMAM Seyed Mehran Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. (2016): 121 - 126. |
| MLA | SAHEBZADEH Narges,BAF Morteza Mazloum Farsi,HOMAM Seyed Mehran Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. , 2016, ss.121 - 126. |
| AMA | SAHEBZADEH N,BAF M,HOMAM S Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. . 2016; 121 - 126. |
| Vancouver | SAHEBZADEH N,BAF M,HOMAM S Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. . 2016; 121 - 126. |
| IEEE | SAHEBZADEH N,BAF M,HOMAM S "Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran." , ss.121 - 126, 2016. |
| ISNAD | SAHEBZADEH, Narges vd. "Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran". (2016), 121-126. |
| APA | SAHEBZADEH N, BAF M, HOMAM S (2016). Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. Türk Nöroloji Dergisi, 22(3), 121 - 126. |
| Chicago | SAHEBZADEH Narges,BAF Morteza Mazloum Farsi,HOMAM Seyed Mehran Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. Türk Nöroloji Dergisi 22, no.3 (2016): 121 - 126. |
| MLA | SAHEBZADEH Narges,BAF Morteza Mazloum Farsi,HOMAM Seyed Mehran Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. Türk Nöroloji Dergisi, vol.22, no.3, 2016, ss.121 - 126. |
| AMA | SAHEBZADEH N,BAF M,HOMAM S Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. Türk Nöroloji Dergisi. 2016; 22(3): 121 - 126. |
| Vancouver | SAHEBZADEH N,BAF M,HOMAM S Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran. Türk Nöroloji Dergisi. 2016; 22(3): 121 - 126. |
| IEEE | SAHEBZADEH N,BAF M,HOMAM S "Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran." Türk Nöroloji Dergisi, 22, ss.121 - 126, 2016. |
| ISNAD | SAHEBZADEH, Narges vd. "Sleep Quality and Cognitive Impairment in Patients with Parkinson's Disease in Iran". Türk Nöroloji Dergisi 22/3 (2016), 121-126. |
